Evidence map›Paper›PMID 34747540›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2022

Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain.

Pablo Rodriguez Del Rio, Davide Caimmi, Pilar Rico, Carmen Vidal, Moreno Carmen, Ileana M Pintoiu, Jose M Beitia Mazuecos, David Gonzalez de Olano, Pedro Cuesta Alvaro, Pascal Demoly and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Allergic diseases and immunodeficiencies in children, lessons learnt from COVID-19 pandemic by 2022: A statement from the EAACI-section on pediatrics.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Article
  6. Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Pablo Rodriguez Del RioAllergy Department, Hospital Infantil Universitario Niño Jesus, Madrid, Spain.ORCID 0000-0002-0783-1988
Davide CaimmiDivision of Allergy, Department of Pulmonology, Arnaud de Villeneuve Hospital, University Hospital of Montpellier, Univ Montpellier, Montpellier, France.ORCID 0000-0003-4481-6194
Pilar RicoIMMA (Instituto de Medicina Molecular Aplicada), Facultad de Medicina San Pablo CEU, Madrid, Spain.
Carmen VidalAllergy Department, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.ORCID 0000-0002-2844-2754
Moreno CarmenHospital Reina Sofia, Instituto Maimonides de Investigacion Biomedica de Córdoba, Red ARADyAL, Cordoba, Spain.
Ileana M PintoiuPrivate Practice Allergist, Baie-Mahault, Guadeloupe, France.
Jose M Beitia MazuecosAllergy Department, H. U de Guadalajara, Guadalajara, Spain.
David Gonzalez de OlanoAllergy Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
Pedro Cuesta AlvaroComputing Services, Research Support, Complutense University of Madrid, Madrid, Spain.
Pascal DemolyDivision of Allergy, Department of Pulmonology, Arnaud de Villeneuve Hospital, University Hospital of Montpellier, Univ Montpellier, Montpellier, France.ORCID 0000-0001-7827-7964
Moises A CalderonSection of Allergy and Clinical Immunology, Imperial College London-NHLI, London, UK.

Funding

ALKstallergenes
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Desensitization, ImmunologicQuarantineAnti-Allergic AgentsFranceHumansHypersensitivityPractice Patterns, Physicians'SARS-CoV-2SpainAnti-Allergic Agents

Identifiers

PMID34747540
PMCPMC8653094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.